Compare, Analyse Lupin with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-20
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8823,043-   
Low Rs5052,643-   
Sales per share (Unadj.) Rs339.41,746.3-  
Earnings per share (Unadj.) Rs-5.9109.1-  
Cash flow per share (Unadj.) Rs15.5250.2-  
Dividends per share (Unadj.) Rs6.0095.50-  
Dividend yield (eoy) %0.93.4 25.8%  
Book value per share (Unadj.) Rs276.71,939.8-  
Shares outstanding (eoy) m453.00848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.01.6 125.5%   
Avg P/E ratio x-116.626.1 -447.5%  
P/CF ratio (eoy) x44.811.4 394.6%  
Price / Book Value ratio x2.51.5 171.0%  
Dividend payout %-100.987.5 -115.3%   
Avg Mkt Cap Rs m314,2012,410,949 13.0%   
No. of employees `00018.344.9 40.7%   
Total wages/salary Rs m29,8680-   
Avg. sales/employee Rs Th8,400.632,949.0 25.5%   
Avg. wages/employee Rs Th1,632.00-   
Avg. net profit/employee Rs Th-147.22,058.3 -7.2%   
INCOME DATA
Net Sales Rs m153,7481,480,891 10.4%  
Other income Rs m4,8380-   
Total revenues Rs m158,5851,480,891 10.7%   
Gross profit Rs m24,849405,543 6.1%  
Depreciation Rs m9,702119,702 8.1%   
Interest Rs m3,63029,087 12.5%   
Profit before tax Rs m16,355256,754 6.4%   
Minority Interest Rs m41,166 0.3%   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,521-168,545 4.5%   
Tax Rs m11,571-3,135 -369.1%   
Profit after tax Rs m-2,69492,510 -2.9%  
Gross profit margin %16.227.4 59.0%  
Effective tax rate %70.8-1.2 -5,795.0%   
Net profit margin %-1.86.2 -28.0%  
BALANCE SHEET DATA
Current assets Rs m154,1321,000,188 15.4%   
Current liabilities Rs m92,252872,249 10.6%   
Net working cap to sales %40.28.6 465.9%  
Current ratio x1.71.1 145.7%  
Inventory Days Days8291 90.4%  
Debtors Days Days12996 134.8%  
Net fixed assets Rs m89,082483,692 18.4%   
Share capital Rs m9063,645 24.9%   
"Free" reserves Rs m124,4610-   
Net worth Rs m125,3671,644,989 7.6%   
Long term debt Rs m17,933757,212 2.4%   
Total assets Rs m249,8393,384,310 7.4%  
Interest coverage x5.59.8 56.0%   
Debt to equity ratio x0.10.5 31.1%  
Sales to assets ratio x0.60.4 140.6%   
Return on assets %0.43.6 10.4%  
Return on equity %-2.15.6 -38.2%  
Return on capital %8.74.9 177.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,9800-   
CASH FLOW
From Operations Rs m14,688235,977 6.2%  
From Investments Rs m11,070-83,616 -13.2%  
From Financial Activity Rs m-8,906-283,071 3.1%  
Net Cashflow Rs m16,853-130,710 -12.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 72.9 Rs / USD

Compare LUPIN With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare LUPIN With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFE SCIENCES  DR. DATSONS LABS  



Today's Market

Wipro's Biggest Acquisition, Vodafone Idea Fundraising Plan, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed huge selling during closing hours on Friday and ended lower.

Related Views On News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

LUPIN SHARE PRICE


Mar 5, 2021 (Close)

TRACK LUPIN

MORE ON LUPIN

LUPIN 5-YR ANALYSIS

COMPARE LUPIN WITH

FEATURED VIDEOS

A Time Correction in the Nifty

The Best Stocks in a Volatile Market

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

More Featured Videos

MARKET STATS